Antilipolytic effect of propranolol in the dog

A. O. Grassi; M. N.F. de Lew; H. E. Cingolani

doi:10.1016/0024-3205(69)90053-8

Antilipolytic effect of propranolol in the dog

A. O. Grassi, M. N.F. de Lew, H. E. Cingolani

Research output: Contribution to journal › Article › peer-review

6 Scopus citations

Abstract

1 mg/kg body weight dose of propranolol, a blocking agent of the β-adrenergic receptors, was administered to anesthetized and unanesthetized dogs that were trained and tranquilized.-. Under these conditions the metabolic variations detected in plasma were the following: 1. 1) Decrease in the level of FFA 2. 2) Decrease in glycerol 3. 3) Increase in the level of glucose. The decrease of the glycerol and FFA concentrations seemed to indicate an antilipolytic effect of propranolol in the intact, sedated dog.-.

Original language	English (US)
Pages (from-to)	1239-1245
Number of pages	7
Journal	Life Sciences
Volume	8
Issue number	21 PART 1
DOIs	https://doi.org/10.1016/0024-3205(69)90053-8
State	Published - Nov 1 1969
Externally published	Yes

ASJC Scopus subject areas

General Biochemistry, Genetics and Molecular Biology
Pharmacology, Toxicology and Pharmaceutics(all)

Access to Document

10.1016/0024-3205(69)90053-8

Cite this

@article{12a5e9149b584e5382e8211baff6d43b,

title = "Antilipolytic effect of propranolol in the dog",

abstract = "1 mg/kg body weight dose of propranolol, a blocking agent of the β-adrenergic receptors, was administered to anesthetized and unanesthetized dogs that were trained and tranquilized.-. Under these conditions the metabolic variations detected in plasma were the following: 1. 1) Decrease in the level of FFA 2. 2) Decrease in glycerol 3. 3) Increase in the level of glucose. The decrease of the glycerol and FFA concentrations seemed to indicate an antilipolytic effect of propranolol in the intact, sedated dog.-.",

author = "Grassi, {A. O.} and {de Lew}, {M. N.F.} and Cingolani, {H. E.}",

year = "1969",

month = nov,

day = "1",

doi = "10.1016/0024-3205(69)90053-8",

language = "English (US)",

volume = "8",

pages = "1239--1245",

journal = "Life Sciences",

issn = "0024-3205",

publisher = "Elsevier Inc.",

number = "21 PART 1",

}

TY - JOUR

T1 - Antilipolytic effect of propranolol in the dog

AU - Grassi, A. O.

AU - de Lew, M. N.F.

AU - Cingolani, H. E.

PY - 1969/11/1

Y1 - 1969/11/1

N2 - 1 mg/kg body weight dose of propranolol, a blocking agent of the β-adrenergic receptors, was administered to anesthetized and unanesthetized dogs that were trained and tranquilized.-. Under these conditions the metabolic variations detected in plasma were the following: 1. 1) Decrease in the level of FFA 2. 2) Decrease in glycerol 3. 3) Increase in the level of glucose. The decrease of the glycerol and FFA concentrations seemed to indicate an antilipolytic effect of propranolol in the intact, sedated dog.-.

AB - 1 mg/kg body weight dose of propranolol, a blocking agent of the β-adrenergic receptors, was administered to anesthetized and unanesthetized dogs that were trained and tranquilized.-. Under these conditions the metabolic variations detected in plasma were the following: 1. 1) Decrease in the level of FFA 2. 2) Decrease in glycerol 3. 3) Increase in the level of glucose. The decrease of the glycerol and FFA concentrations seemed to indicate an antilipolytic effect of propranolol in the intact, sedated dog.-.

UR - http://www.scopus.com/inward/record.url?scp=0014603884&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0014603884&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(69)90053-8

DO - 10.1016/0024-3205(69)90053-8

M3 - Article

C2 - 5358660

AN - SCOPUS:0014603884

SN - 0024-3205

VL - 8

SP - 1239

EP - 1245

JO - Life Sciences

JF - Life Sciences

IS - 21 PART 1

ER -

Antilipolytic effect of propranolol in the dog

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this